Caption Management, LLC Kezar Life Sciences, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $540 - $1,270	-500 Reduced 0.11%	449,500 $534,000
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $1.41 Million - $3.29 Million	450,000 New	450,000 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $2.96 Million - $3.99 Million	-370,700 Reduced 61.63%	230,800 $1.99 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $2.55 Million - $9.53 Million	556,500 Added 1236.67%	601,500 $4.97 Million
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $553,500 - $824,849	45,000 New	45,000 $748,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.